2026 Pharma CX Marketing Summit

For decades, HCP engagement has meant segmenting physicians into broad buckets — specialty, tier, prescribing volume — and hoping the message lands. AI is breaking that model. Today's HCPs expect experiences shaped by their actual behavior, preferences, and moment-in-time needs, not a persona built from last year's data. But personalization at scale raises hard questions pharma marketers can't ignore: How much precision is genuinely useful versus invasive? Where does AI-driven relevance end and algorithmic guesswork begin? And what does trust look like when the HCP knows they're being read by a machine? This panel brings together CX and digital leaders reimagining the HCP journey from the ground up — exploring what it actually takes to move from segmentation to true individualization, and what pharma stands to gain (or risk) in getting there first.

The traditional marketing funnel assumes a patient moves neatly from awareness to consideration to action. That assumption no longer holds. Today's patients bounce between search, social, symptom-checkers, AI chatbots, caregiver forums, and their HCP — often in a different order every time, and rarely in a straight line. This panel explores what happens when journey mapping stops trying to force patients into a linear path and instead reflects how people actually move: nonlinear, recursive, and driven as much by moments of doubt as moments of intent. In this session, participants share how they are rethinking journey design for a post-linear reality — what gets built differently, what gets measured differently, and what pharma marketers need to unlearn about the funnel model that's shaped the industry for decades.